LYRA
USDLyra Therapeutics Inc. Common Stock
$12.830-0.500 (-3.751%)
Precio en Tiempo Real
Healthcare
Biotecnología
Estados Unidos
Gráfico de Precios
Loading Chart...
Métricas Clave
Métricas de Mercado
Apertura
$13.330
Máximo
$13.502
Mínimo
$11.670
Volumen
0.20M
Fundamentos de la Empresa
Capitalización de Mercado
17.0M
Industria
Biotecnología
País
United States
Estadísticas de Negociación
Volumen Promedio
0.65M
Bolsa
NCM
Moneda
USD
Rango de 52 Semanas
Mínimo $3.81Actual $12.830Máximo $37.5
Noticias Relacionadas
Analyst Upgrades
HC Wainwright & Co. Maintains Neutral on Lyra Therapeutics, Raises Price Target to $16
HC Wainwright & Co. analyst Matthew Caufield maintains Lyra Therapeutics with a Neutral and raises the price target from $2 to $16.
Ver más
GlobeNewswire
Lyra Therapeutics Reports Positive Results from the ENLIGHTEN 2 Phase 3 Trial of LYR-210 Achieving Statistically Significant Results for Primary and Key Secondary Endpoints in the Treatment of Chronic Rhinosinusitis (CRS)
ENLIGHTEN 2 trial met primary endpoint with LYR-210 demonstrating statistically significant improvement in the composite of the three cardinal symptoms (3CS) of CRS at 24 weeks (p=0.0078)ENLIGHTEN 2 trial also showed
Ver más
Acciones Relacionadas
Mantente Actualizado
Configura alertas de precio, recibe actualizaciones de análisis de IA y noticias de mercado en tiempo real.